Novel genetic and epigenetic alterations in ... - Ous-research.no

ReferencesT, Song X, Day RH, Sledziewski AZ, Lofton-Day C (2008) Sensitive Detection ofColorectal Cancer in Peripheral Blood by Septin 9 DNA Methylation Assay.PLoS ONE 3(11): e3759179. Locker GY, Hamilton S, Harris J, Jessup JM, Kemeny N, Macdonald JS, SomerfieldMR, Hayes DF, Bast RC, Jr. (2006) ASCO 2006 update of recommendations forthe use of tumor markers in gastrointestinal cancer. J Clin Oncol 24(33): 5313-5327180. Løvig T, Meling GI, Diep CB, Thorstensen L, Norheim AS, Lothe RA, Rognum TO(2002) APC and CTNNB1 mutations in a large series of sporadic colorectalcarcinomas stratified by the microsatellite instability status. Scand JGastroenterol 37(10): 1184-1193181. Diep CB, Thorstensen L, Meling GI, Skovlund E, Rognum TO, Lothe RA (2003)Genetic tumor markers with prognostic impact in Dukes' stages B and Ccolorectal cancer patients. J Clin Oncol 21(5): 820-829182. Børresen-Dale AL, Lothe RA, Meling GI, Hainaut P, Rognum TO, Skovlund E(1998) TP53 and long-term prognosis in colorectal cancer: mutations in the L3zinc-binding domain predict poor survival. Clin Cancer Res 4(1): 203-210183. Andreyev HJ, Norman AR, Cunningham D, Oates J, Dix BR, Iacopetta BJ, Young J,Walsh T, Ward R, Hawkins N, Beranek M, Jandik P, Benamouzig R, Jullian E,Laurent-Puig P, Olschwang S, Muller O, Hoffmann I, Rabes HM, Zietz C, TroungosC, Valavanis C, Yuen ST, Ho JW, Croke CT, O'Donoghue DP, Giaretti W, RapalloA, Russo A, Bazan V, Tanaka M, Omura K, Azuma T, Ohkusa T, Fujimori T, OnoY, Pauly M, Faber C, Glaesener R, de Goeij AF, Arends JW, Andersen SN, Løvig T,Breivik J, Gaudernack G, Clausen OP, De Angelis PD, Meling GI, Rognum TO,Smith R, Goh HS, Font A, Rosell R, Sun XF, Zhang H, Benhattar J, Losi L, Lee JQ,Wang ST, Clarke PA, Bell S, Quirke P, Bubb VJ, Piris J, Cruickshank NR, Morton D,Fox JC, Al-Mulla F, Lees N, Hall CN, Snary D, Wilkinson K, Dillon D, Costa J,Pricolo VE, Finkelstein SD, Thebo JS, Senagore AJ, Halter SA, Wadler S, Malik S,Krtolica K, Urosevic N (2001) Kirsten ras mutations in patients with colorectalcancer: the 'RASCAL II' study. Br J Cancer 85(5): 692-696184. Lewis KA, Bakkum-Gamez J, Loewen R, French AJ, Thibodeau SN, Cliby WA(2007) Mutations in the ataxia telangiectasia and rad3-related-checkpointkinase 1 DNA damage response axis in colon cancers. Genes ChromosomesCancer 46(12): 1061-1068185. Fernandez-Peralta AM, Nejda N, Oliart S, Medina V, Azcoita MM, Gonzalez-Aguilera JJ (2005) Significance of mutations in TGFBR2 and BAX in neoplasticprogression and patient outcome in sporadic colorectal tumors with highfrequencymicrosatellite instability. Cancer Genet Cytogenet 157(1): 18-24186. Jung B, Smith EJ, Doctolero RT, Gervaz P, Alonso JC, Miyai K, Keku T, SandlerRS, Carethers JM (2006) Influence of target gene mutations on survival, stage82